KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) EPS (Weighted Average and Diluted): 2012-2025

Historic EPS (Weighted Average and Diluted) for Sarepta Therapeutics (SRPT) over the last 5 years, with Jun 2025 value amounting to -$4.46.

  • Sarepta Therapeutics' EPS (Weighted Average and Diluted) fell 1305.41% to -$4.46 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.19, marking a year-over-year increase of 57.64%. This contributed to the annual value of $2.34 for FY2024, which is 140.34% up from last year.
  • According to the latest figures from Q2 2025, Sarepta Therapeutics' EPS (Weighted Average and Diluted) is -$4.46, which was down 385.90% from $1.56 recorded in Q4 2024.
  • Sarepta Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $1.56 during Q4 2024, with a 5-year trough of -$5.84 in Q2 2023.
  • For the 3-year period, Sarepta Therapeutics' EPS (Weighted Average and Diluted) averaged around -$1.10, with its median value being $0.34 (2024).
  • In the last 5 years, Sarepta Therapeutics' EPS (Weighted Average and Diluted) surged by 173.91% in 2024 and then slumped by 1,305.41% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.43 in 2021, then climbed by 13.29% to -$1.24 in 2022, then skyrocketed by 161.29% to $0.76 in 2023, then skyrocketed by 105.26% to $1.56 in 2024, then tumbled by 1,305.41% to -$4.46 in 2025.
  • Its last three reported values are -$4.46 in Q2 2025, $1.56 for Q4 2024, and $0.34 during Q3 2024.